Total: 3 |
|
PMID (PMCID) | ||
---|---|---|
26782803 |
FEMALE | |
Critical Pitfalls in the use of BRAF Mutation as a Diagnostic Tool in Thyroid Nodules: a Case Report. | ||
Kuhn E, Ragazzi M, Zini M, Giordano D, Nicoli D, Piana S. Endocr Pathol. 2016;27(3):220-3. |
||
Notably, BRAF (V600E) mutation is common in melanoma, colorectal carcinoma, lung carcinoma, ovarian carcinoma, brain tumors, hairy cell leukemia, multiple myeloma, and histiocytoses. | ||
2743258 |
FEMALE | |
Secondary acute myelocytic leukemia after adjuvant therapy for early-stage breast carcinoma. A new complication of cyclophosphamide, methotrexate, and 5-fluorouracil therapy. | ||
Geller RB, Boone LB, Karp JE, Davidson N, Selonick SE, Edwards J, Burke PJ. Cancer. 1989;64(3):629-34. |
||
The occurrence of treatment-related hematologic malignancies after adjuvant therapy with alkylating agents for gastrointestinal cancers, ovarian carcinoma, and breast cancer and after treatment for Hodgkin's disease, non-Hodgkin's lymphoma, germ-cell tumors, and multiple myeloma has been well documented. | ||
3130316 |
MIXED_SAMPLE | Adult |
Treatment of advanced malignancies with ifosfamide under protection with mesna. | ||
Li GC, Brock N, Li JQ, Guan ZZ, He YJ. Int J Clin Pharmacol Res. 1988;8(1):55-67. |
||
This series comprised eight cases of soft tissue sarcoma, nine cases of ovarian carcinoma, five cases of non-seminomatous testicular tumour, 11 cases of bronchogenic carcinoma, three cases of renal carcinoma, seven cases of non-Hodgkin's lymphoma, two cases of skeletal fibrosarcoma, two cases of breast carcinoma, one case each of Ewing's tumour, prostatic carcinoma, seminoma, plasma cell tumour, multiple myeloma, malignant teratoma, nasopharyngeal carcinoma, Wilms's tumour, neuroblastoma and mycosis fungoides. |